Alan B. Lancz & Associates, Inc. Becton Dickinson & CO Transaction History
Alan B. Lancz & Associates, Inc.
- $108 Million
- Q3 2024
A detailed history of Alan B. Lancz & Associates, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 910 shares of BDX stock, worth $215,943. This represents 0.2% of its overall portfolio holdings.
Number of Shares
910
Previous 910
-0.0%
Holding current value
$215,943
Previous $212,000
3.3%
% of portfolio
0.2%
Previous 0.21%
Shares
3 transactions
Others Institutions Holding BDX
# of Institutions
1,737Shares Held
253MCall Options Held
586KPut Options Held
656K-
Vanguard Group Inc Valley Forge, PA26.3MShares$6.24 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$5.28 Billion0.12% of portfolio
-
State Street Corp Boston, MA13.8MShares$3.29 Billion0.14% of portfolio
-
Morgan Stanley New York, NY11.3MShares$2.69 Billion0.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.7MShares$2.55 Billion0.3% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $67.7B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...